TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Chemists against online delivery of medicines, write to Drug Controller

Photo for representational purpose only.

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

The Punjab Chapter of the All India Organisation of Chemists and Druggists (AIOCD) has expressed concern over the alleged partnership between Swiggy Instamart and PharmEasy to deliver medicines on the door step of residents. The AIOCD has written to Drug Controller General of India (DCGI) in this regard.

Advertisement

The AIOCD said this move was against standards set under the Indian law and could create many serious health and safety-related threats.

Advertisement

Surinder Duggal, president, Punjab Chemist Association, said, “There are strict rules for selling medicines in India which ensure safety of patients.” He said online delivery of medicines was not safe for patients.

“This partnership is likely to ignore standards like proper prescription checking and patient identification and endanger health of residents,” he said. Duggal said despite efforts of the government to tackle the threat of anti-microbial resistance, the unregulated operation of e-pharmacies could further increase the problem.

The association said the online delivery of medicines would also jeopardize the livelihood of nearly 13 lakh chemists across the country who sold medicines to citizens. The association said ultra-fast delivery model might increase the possibility of patients ending up buying expired or counterfeit medicines which could be harmful for their health.

Advertisement

Advertisement
Show comments
Advertisement